Optimal surgical cytoreduction continues to be an important prognostic variable in patients with ovarian cancer independent of p53 mutational status. Among patients with suboptimal cytoreduction a p53 mutation may offer a survival advantage.
Keywords: P53, cytoreductive surgery, survival, ovarian cancer
How to Cite:
Engle, D. & Fornalik, H. & Neff, T. & Button, A. & Collins, K. & Ahmed, A. & Bender, D. & Lutgendorf, S. & Goodheart, M., (2011) “Comparison of P53 mutation status, primary cytoreductive surgical outcomes, and overall survival in patients with ovarian cancer”, Proceedings in Obstetrics and Gynecology 2(1), 1-2. doi: https://doi.org/10.17077/2154-4751.1107
Rights: Copyright © David Engle, Hubert Fornalik, Traci Neff, Anna Button, K Collins, Amina Ahmed, David Bender, Susan Lutgendorf, Michael J. Goodheart, 2011